A randomized, double-blind, placebo-controlled parallel trial to test the effect of inulin supplementation on migraine headache characteristics, quality of life and mental health symptoms in women with migraine

被引:0
|
作者
Vajdi, Mahdi [1 ]
Khorvash, Fariborz [2 ]
Askari, Gholamreza [1 ]
机构
[1] Isfahan Univ Med Sci, Dept Community Nutr, Sch Nutr & Food Sci, Esfahan, Iran
[2] Isfahan Univ Med Sci, Neurol Res Ctr, Sch Med, Esfahan, Iran
关键词
GUT-BRAIN; QUESTIONNAIRE; PROBIOTICS; VALIDITY; ANXIETY; RELIABILITY; MICROBIOME; MECHANISMS; DISABILITY; DEPRESSION;
D O I
10.1039/d4fo02796e
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Migraine is a complex neurovascular disorder characterized by recurrent headache attacks that are often accompanied by symptoms such as vomiting, nausea, and sensitivity to sound or light. Preventing migraine attacks is highly important. Recent research has indicated that alterations in gut microbiota may influence the underlying mechanisms of migraines. This study aimed to investigate the effects of inulin supplementation on migraine headache characteristics, quality of life (QOL), and mental health symptoms in women with migraines. In a randomized double-blind placebo-controlled trial, 80 women with migraines aged 20 to 50 years were randomly assigned to receive 10 g day(-1) of inulin or a placebo supplement for 12 weeks. Severity, frequency, and duration of migraine attacks, as well as depression, anxiety, stress, QOL, and headache impact test (HIT-6) scores, were examined at the start of the study and after 12 weeks of intervention. In this study, the primary outcome focused on the frequency of headache attacks, while secondary outcomes encompassed the duration and severity of headache attacks, QOL, and mental health. There was a significant reduction in severity (-1.95 vs. -0.84, P = 0.004), duration (-6.95 vs. -2.05, P = 0.023), frequency (-2.09 vs. -0.37, P < 0.001), and HIT-6 score (-10.30 vs. -6.52, P < 0.023) in the inulin group compared with the control. Inulin supplementation improved mental health symptoms, including depression (-4.47 vs. -1.45, P < 0.001), anxiety (-4.37 vs. -0.70, P < 0.001), and stress (-4.40 vs. -1.50, P < 0.001). However, no significant difference was observed between the two groups regarding changes in QOL score. This study provides evidence supporting the beneficial effects of inulin supplement on migraine symptoms and mental health status in women with migraines. Further studies are necessary to confirm these findings.
引用
收藏
页码:10088 / 10098
页数:11
相关论文
共 50 条
  • [1] The effects of synbiotic supplementation on oxidative stress and clinical symptoms in women with migraine: A double-blind, placebo-controlled, randomized trial
    Ghavami, Abed
    Khorvash, Fariborz
    Khalesi, Saman
    Heidari, Zahra
    Askari, Gholamreza
    JOURNAL OF FUNCTIONAL FOODS, 2021, 86
  • [2] Oxcarbazepine in migraine headache - A double-blind, randomized, placebo-controlled study
    Silberstein, S.
    Saper, J.
    Berenson, F.
    Somogyi, M.
    McCague, K.
    D'Souza, J.
    NEUROLOGY, 2008, 70 (07) : 548 - 555
  • [3] The effects of inulin supplementation on clinical indices, oxidative stress and inflammatory biomarkers in women with migraine: A double-blind, placebo-controlled, randomized trial
    Vajdi, Mahdi
    Khorvash, Fariborz
    Askari, Gholamreza
    JOURNAL OF FUNCTIONAL FOODS, 2024, 121
  • [4] RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF FEVERFEW IN MIGRAINE PREVENTION
    MURPHY, JJ
    HEPTINSTALL, S
    MITCHELL, JRA
    LANCET, 1988, 2 (8604): : 189 - 192
  • [5] The Effects of probiotic supplementation on chronic migraine(CM) headache: a randomized placebo-controlled double-blind study
    Seyfi-Shahpar, Maryam
    Martami, Fahimeh
    Togha, Mansoureh
    Ghorbani, Zeinab
    Jahromi, Soodeh Razeghi
    Ansari, Hossein
    JOURNAL OF HEADACHE AND PAIN, 2017, 18
  • [6] The effects of folic acid and pyridoxine supplementation on characteristics of migraine attacks in migraine patients with aura: A double-blind, randomized placebo-controlled, clinical trial
    Askari, Gholamreza
    Nasiri, Morteza
    Mozaffari-Khosravi, Hassan
    Rezaie, Masod
    Bagheri-Bidakhavidi, Mandieh
    Sadeghi, Omid
    NUTRITION, 2017, 38 : 74 - 79
  • [7] Efficacy of Enalapril in Migraine Prophylaxis: A Randomized, Double-blind, Placebo-controlled Trial
    Sonbolestan, Seyed Ali
    Heshmat, Kiyan
    Javanmard, Shaghayegh Haghjooy
    Saadatnia, Mohammad
    INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 2013, 4 (01) : 72 - 77
  • [8] Topiramate for the prevention of paediatric migraine: a randomized, double-blind, placebo-controlled trial
    Winner, P
    Pearlman, EM
    Linder, S
    Jordan, D
    Fisher, A
    Hulihan, J
    CEPHALALGIA, 2004, 24 (09) : 814 - 814
  • [9] Arterial effects of acupuncture in migraine: A randomized, double-blind, placebo-controlled trial
    Boutouyrie, P
    Laloux, B
    Corvisier, R
    Vulser, C
    Girard, A
    Laurent, S
    HYPERTENSION, 2005, 46 (04) : 897 - 897
  • [10] Topiramate for migraine prevention in children: A randomized, double-blind, placebo-controlled trial
    Winner, P
    Pearlman, EM
    Linder, SL
    Jordan, DM
    Fisher, AC
    Hulihan, J
    HEADACHE, 2005, 45 (10): : 1304 - 1312